SurModics Inc.+$0.72 $11.65 A Rodman & Renshaw analyst upgraded the shares to "market perform," saying the share price already reflects the risks the medical technology company is facing. (Ticker: SRDX)
about the writer
The U.S. stock market roared back on Friday, as technology stocks recovered much of their losses from earlier in the week and bitcoin halted its plunge, at least for now.